Latest research on prolia. FDA approves first interchangeable biosimilars to Prolia and Xgeva to treat certain types of osteoporosis and prevent bone events in cancer Find data from the real-world study on Prolia® comparing the risk of fracture in women with postmenopausal osteoporosis. Case in point: A recent study suggests GLP-1 medications may be linked to slightly higher risks of osteoporosis and gout. Osteoporosis occurs when bones become weak, while gout is a type of inflammatory arthritis. Denosumab is a potent antiresorptive medication for treatment of osteoporosis, with clinical trial data for up to 10 years of treatment that demonstrate its safety and efficacy in reducing fracture risk. Explore health, wellness, and fitness topics with expert advice, tips, and insights from The New York Times Well section. New research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and gout. See Full Prescribing & Safety Information. Mar 2, 2026 · GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Mar 2, 2026 · According to a new study presented at the American Academy of Orthopaedic Surgeons' annual meeting, GLP-1 drugs like Ozempic and Wegovy may be linked to a slightly higher risk of osteoporosis and gout. is conducting a Phase 4 clinical study titled ‘A Phase 4 Single-arm Open-label Study for the Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis 5 days ago · And you should! But like any medication, these drugs are still being studied, and new research is giving us important information about how to use them safely. The goal of this research isn't to scare people away from these life-changing medications, but to help them use them more safely. The observational study analyzed medical records of over 146,000 adults with obesity and type 2 diabetes, finding a 30% increased risk of osteoporosis and a 12% increased risk of gout among GLP 2 days ago · New research links GLP-1 drugs like Ozempic to higher fracture risk, osteoporosis and gout, prompting experts to urge bone health screening in older adults. Review clinical trials and real-world evidence for Prolia® (denosumab), including study designs, efficacy data, and safety profiles. . Mar 7, 2025 · By harnessing advances in biotechnology, exploring new therapeutic indications, and leveraging comprehensive real-world data, the next generation of Prolia research and development aims not only to improve patient quality of life but also to redefine the treatment paradigm for osteoporosis. Mar 2, 2026 · A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. Amgen Inc. See full prescribing & safety info. According to a study presented at the American Academy of Orthopaedic Surgeons’ 6 days ago · New research has found that GLP-1 medications may be linked to an increased risk of developing gout and osteoporosis People on GLP-1 medications “decrease their intake of food and nutrients 4 days ago · GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better 6 days ago · GLP-1 diabetes and obesity drugs like Ozempic and Wegovy may be linked to a slightly higher risk of osteoporosis and gout, according to new research presented at the annual meeting of the American 6 days ago · Can You Decrease Your Risk of Osteoporosis On GLP-1? Experts explain that it is possible to lower the effects of weight loss medications on your bones. Press Releases NEW DATA FROM AMGEN'S PROLIA® (DENOSUMAB) DEMONSTRATES SIGNIFICANT REDUCTION IN OSTEOPOROTIC FRACTURE RISK COMPARED TO ALENDRONATE Real World Evidence Study Showed use of Prolia Reduced Fracture Risk in Postmenopausal Women With Osteoporosis Versus Alendronate Treatment Despite the availability of safe and effective anti-osteoporosis therapies, osteoporosis continues to be underdiagnosed and undertreated. 4 days ago · Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis Mar 3, 2026 · New safety advisories and side effect warnings for osteoporosis drugs including Fosamax, Actonel, Reclast, Boniva and more. kwxqu sjxwe cvti dizm ewbntvd bflm yuhsc vqpjg gitlevz jrczen